Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

By sjmartinez • May 9, 2024

Alexander GC, Moore TJ, Brass EP. Long-Term Cardiovascular Risks of Psychostimulant Drugs for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). J Am Coll Cardiol. 2024 May 14;83(19):1883-1885. doi: 10.1016/j.jacc.2024.03.409. PMID: 38719368.

Tags: attention deficit disorder with hyperactivity, central nervous system stimulants, Endocrinology, Harbor UCLA, prescribing indicators, prescribing quality, Publications, quality of care

Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease

Ko M, Barai R, Brent G. Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. Cureus. 2024 Oct 15;16(10):e71551. doi: 10.7759/cureus.71551.[...]

Association of BRAF V600E allele frequency with clinicopathologic outcomes in papillary thyroid cancer

Schumm MA, Nikiforov YE, Nikiforova MN, Wald AI, Tseng CH, Smooke-Praw S, Wu JX, Yeh MW, Livhits MJ. Association of BRAF V600E allele frequency with[...]

The Relationship Between Hospital Safety-Net Burden on Outcomes for High-Volume Thyroid Cancer Surgeons

Huston-Paterson HH, Mao YV, Tseng CH, Kim J, Chen DW, Wu JX, Yeh MW. The Relationship Between Hospital Safety-Net Burden on Outcomes for High-Volume Thyroid[...]